Compounds > 1-deoxygluco-heptulose 2-phosphate
Page last updated: 2024-12-07
1-deoxygluco-heptulose 2-phosphate
Description
1-deoxygluco-heptulose 2-phosphate (DHP) is a sugar phosphate that plays a key role in the **Calvin cycle** of photosynthesis, specifically in the **reduction of carbon dioxide**.
Here's a breakdown of its significance:
**What it is:**
* DHP is a seven-carbon sugar phosphate, meaning it contains a phosphate group attached to a seven-carbon sugar molecule.
* It's a crucial intermediate in the Calvin cycle, a series of biochemical reactions that convert carbon dioxide into glucose in plants.
**Why it's important for research:**
* **Understanding photosynthesis:** DHP is a key player in one of the most fundamental processes on Earth. Studying its role helps us understand how plants convert light energy into chemical energy, which is essential for life.
* **Developing new technologies:** DHP and its associated enzymes are being explored for potential applications in biotechnology, such as:
* **Engineering new pathways for carbon fixation:** Modifying the Calvin cycle to increase the efficiency of carbon dioxide conversion into biomass could have implications for biofuel production and climate change mitigation.
* **Developing new biocatalysts:** The enzymes involved in DHP metabolism could be used as biocatalysts for various industrial processes.
* **Studying metabolic regulation:** DHP's role in the Calvin cycle highlights the complexity of metabolic regulation in plants. Researching how its levels are controlled can provide insights into plant growth and development.
* **Potential therapeutic applications:** DHP and its derivatives are being investigated for potential therapeutic applications in various diseases, including cancer and diabetes.
**Research Focus:**
Current research on DHP focuses on:
* **Understanding the mechanism of its formation and its role in the Calvin cycle.**
* **Identifying the enzymes involved in its metabolism and their regulatory mechanisms.**
* **Exploring its potential applications in biotechnology and medicine.**
Overall, DHP is a fascinating molecule that holds immense potential for advancing our understanding of photosynthesis, developing new technologies, and improving human health.
1-deoxygluco-heptulose 2-phosphate: RN & structure given in first source; RN not in Chemline 3/85 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 124823 |
SCHEMBL ID | 4312544 |
MeSH ID | M0130034 |
Synonyms (16)
Synonym |
H2P , |
heptulose-2-phosphate |
6GPB , |
DB04195 |
[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-methyloxan-2-yl] dihydrogen phosphate |
92642-58-5 |
SCHEMBL4312544 |
1-deoxygluco-heptulose 2-phosphate |
heptulose-2-p |
heptulose 2-phosphate |
alpha-d-gluco-2-heptulopyranose, 1-deoxy-, 2-(dihydrogen phosphate) |
1-deoxy-d-gluco-heptulose 2-phosphate |
1-deoxy-2-o-phosphono-alpha-d-gluco-hept-2-ulopyranose |
DTXSID70919034 |
1-deoxy-2-o-phosphonohept-2-ulopyranose |
Q27095022 |
Protein Targets (1)
Inhibition Measurements
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.60
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.60 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.39 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |